VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,475,260 | -8.7% | 54,822 | +2.1% | 0.05% | -16.4% |
| Q2 2023 | $1,616,485 | -17.9% | 53,686 | -11.8% | 0.06% | -29.5% |
| Q1 2023 | $1,969,803 | +31.9% | 60,890 | +16.8% | 0.08% | +2.6% |
| Q4 2022 | $1,493,676 | +256.5% | 52,117 | +200.2% | 0.08% | +216.7% |
| Q3 2022 | $419,000 | -17.4% | 17,358 | -6.3% | 0.02% | -17.2% |
| Q2 2022 | $507,000 | -23.6% | 18,533 | +7.0% | 0.03% | -12.1% |
| Q1 2022 | $664,000 | +3.1% | 17,314 | -13.8% | 0.03% | +6.5% |
| Q4 2021 | $644,000 | +1.4% | 20,092 | -6.8% | 0.03% | -11.4% |
| Q3 2021 | $635,000 | -9.2% | 21,557 | +4.9% | 0.04% | -18.6% |
| Q2 2021 | $699,000 | +2.3% | 20,557 | -2.2% | 0.04% | -10.4% |
| Q1 2021 | $683,000 | -10.8% | 21,009 | +0.2% | 0.05% | -14.3% |
| Q4 2020 | $766,000 | -99.9% | 20,961 | -24.2% | 0.06% | -40.4% |
| Q3 2020 | $1,082,000,000 | – | 27,649 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |